2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Pancreatic Cancer
Pancreatic cancer remains one of the most challenging malignancies to treat, with a high mortality rate and limited therapeutic options. However, recent advancements in cancer research offer hope for improved outcomes. Targeted therapies, immunotherapy, and precision medicine approaches are being investigated to tackle the complex nature of pancreatic tumors. Novel biomarkers are being identified to aid in early detection and personalized treatment strategies. Additionally, advancements in imaging techniques such as MRI and PET scans enable more accurate staging and monitoring of the disease. Clinical trials are actively exploring innovative treatments, including combination therapies and gene therapies, to enhance survival rates and quality of life for pancreatic cancer patients. Despite the formidable obstacles, ongoing research efforts promise to revolutionize the management of this devastating disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China